Chen, Peter J. http://orcid.org/0000-0002-1094-7180
Liu, David R.
Article History
Accepted: 30 September 2022
First Online: 7 November 2022
Competing interests
: The authors have filed patent applications on gene-editing technologies through the Broad Institute of MIT and Harvard. P.J.C. is currently an employee of Prime Medicine. D.R.L. is a consultant and equity owner of Beam Therapeutics, Pairwise Plants, Prime Medicine, Chroma Medicine, and Nvelop Therapeutics, companies that use or deliver genome-editing or genome-engineering technologies.